OOIR: Observatory of International Research

Papers

(The H4-Index of Schizophrenia Research is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Elevated triglycerides and low triiodothyronine: Key risk factors for coronary artery calcification in patients with schizophrenia	110
Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in the UK	85
Effect of add-on tDCS therapy for auditory hallucinations on frequency and duration deviant mismatch negativity in schizophrenia	82
Meta-analysis of a family history of diabetes in schizophrenia	70
Exploring associations between trait symptoms and speech patterns in schizophrenia spectrum disorders: A mediation analysis	69
Everyday function in schizophrenia: The impact of aerobic endurance and skeletal muscle strength	67
Rethinking psychosis: Time to retire “organic”, “idiopathic” and “secondary”?	60
The impact of daily social support on the associations between daily negative events and daily suspiciousness across different clinical stages of psychosis	57
Automated linguistic analysis in speech samples of Turkish-speaking patients with schizophrenia-spectrum disorders	57
Creating a collaborative culture of learning within a network of community mental health early psychosis programs in Texas	55
Interpersonal distance in schizophrenia: A systematic review	53
Neurodegenerative model of schizophrenia: Growing evidence to support a revisit	53
Deconstructing emotion regulation in schizophrenia: The nature and consequences of abnormalities in monitoring dynamics	52
Reply to Dyadic interaction in schizophrenia – A promising new avenue of investigation?	51
Can clozapine be used for treatment-refractory behavioral and psychological symptoms in dementia patients?	47
Construction of extra-large scale screening tools for risks of severe mental illnesses using real world healthcare data	45
Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma	42
Changes in degree centrality and its associated genes: A longitudinal study of patients with schizophrenia undergoing pharmacological treatment	42
Comments on the manuscript: Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self-experience	41
Testing two theories of social support benefits and implications for individuals with psychotic-like experiences	41
Exploring the conceptualisation, measurement, clinical utility and treatment of formal thought disorder in psychosis: A Delphi study	39
Alterations in fatty acid metabolism in patients with schizophrenia in a multi-omics perspective	39
Exploring phenotypic overlap across schizotypy and autism spectrum conditions in American and Chinese young adults	38
Re-inventing the schizophrenia syndrome: The elusive “theory of everything”	38
Early cognitive development and psychopathology in children at familial high risk for schizophrenia	37

Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis	36
App for independence: A feasibility randomized controlled trial of a digital health tool for schizophrenia spectrum disorders	36
Ethno-racial variation in psychotic experiences in the United States: Findings from the National Latino and Asian American Survey and the National Survey of American Life	35
A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample	35
Comorbid psychosis in temporal lobe epilepsy is associated with auditory emotion recognition impairments	34
Shortening telomere is associated with psychotic dimensions in the general population	34
Searching for the “final proof” of schizophrenia	32
Going the extra mile? The influence of Amisulpride on effort-based decisions	32